tamoxifen and glp-1 medications are everywhere—but what do we actually know about their relationship to breast cancer? Research is still evolving, these medications aren't right for everyone. We're breaking down what scientists know Sharing some research on GLP-1

While the complete scope of their molecular bonds remains under examination, the peptide blend continues to serve as a focal point for active exploration in peptide science

Note: This conversation includes profanity

New J Sci (2014) 2014

Anderson RE, Olaison G, Tysk C, Ekbom A

1.4.3 Limitations of benign and VUS classifications Ultimately, WES is not a genetic oracle, and in contrast to Mendelian diseases which often result from single-gene coding variants (Botstein and Risch, 2003), several complex traits could be driven by noncoding variants that presumably affect gene regulation

Among those patients, 20% pursued plastic surgery post-weight loss, 39% were considering surgery, and 41% were considering nonsurgical options